Heart Arrest: Clinical Trials

29 trials for Heart Arrest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 4 unknown, 3 recruiting, 1 active not recruiting. 29 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 129Completed 18, Unknown 4, Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Suspended 1, Terminated 1
Phase 28Completed 5, Active not recruiting 1, Terminated 1, Unknown 1

Follow Heart Arrest: new trials by email Literature Review of Heart Arrest trials Research Report on Heart Arrest

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The TTM and ASM Trial
Prophylactic ASM, Hypothermic, Normothermic - Critical Care Medicine, Emergency Medical Services
Phase 1Not yet recruitingNational Taiwan University Hospital1002026-09-172026-10-07
Packed Red Blood Cell Transfusion During Cardiac Arrest
Packed Red Blood Cells (1 unit), Packed Red Blood Cells (2 units), Saline - Cardiac Arrest
Phase 1SuspendedNYU Langone Health302026-06-012026-04-09
Post-CA Neuroprotection With Magnesium
Magnesium Sulfate, Saline - Cardiac Arrest, Return of Spontaneous Circulation
Phase 1RecruitingNYU Langone Health1782025-03-252026-04-07
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Hydrogen, Usual care - Cardiac Arrest, Extracorporeal Membrane Oxygenation
Phase 1RecruitingBoston Children's Hospital532024-03-042025-07-03
Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
LX2020 - Arrhythmogenic Cardiomyopathy, PKP2-ACM
Phase 1 / Phase 2Active not recruitingLexeo Therapeutics102024-02-292025-11-12
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
RP-A601 - PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1RecruitingRocket Pharmaceuticals Inc.92023-08-292026-04-16
Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants
Intranasal insulin - Out-Of-Hospital Cardiac Arrest, Healthy
Phase 1CompletedRobert Silbergleit242021-10-042026-03-27
Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival
Morphine, Ketamine Injectable Solution, Saline 0.9% - Cardiac Arrest
Phase 1UnknownUniversity Hospital, Akershus2402021-10-012021-06-11
Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest
Landiolol, Sodium Chloride (NaCl) 0.9% - Cardiac Arrest
Phase 1 / Phase 2UnknownMedical University of Vienna322021-03-032023-03-17
Phase 1 Study of HBN-1
HBN-1 - Cardiac Arrest
Phase 1UnknownHibernaid, Inc182019-10-302019-10-07
Phase 1 Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
Sodium Nitrite - Out-Of-Hospital Cardiac Arrest
Phase 1CompletedUniversity of Washington1202016-12-012018-05-07
TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA
2-Iminobiotin - Cardiac Arrest, Hypoxic Ischemic Brain Injury
Phase 1 / Phase 2TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)212016-05-012021-02-18
Reoxygenation After Cardiac Arrest II (REOX II Study)
Protocol for rapid FiO2 optimization - Cardiac Arrest
Phase 1CompletedThe Cooper Health System162016-04-012022-03-29
Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
Eleclazine, Placebo - LQT2 Syndrome
Phase 1CompletedGilead Sciences132015-07-202020-12-30
The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
Wobenzym plus, PL 1 - Inflammation, Death, Sudden, Cardiac
Phase 1CompletedTechnical University of Munich1602013-08-012015-06-30
Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest
Standard Care, Low Volume Hemofiltration, High Volume Hemofiltration - Cardiac Arrest
Phase 1 / Phase 2CompletedUniversity of Washington22012-01-012016-06-09
Refractory Out-Of-Hospital Cardiac Arrest Treated With Mechanical CPR, Hypothermia, ECMO and Early Reperfusion
Automated CPR, ECMO, Coronary angiography - Cardiac Arrest
Phase 1UnknownBayside Health242010-11-012014-03-10
Cardiopulmonary Resuscitation (CPR) Dissemination Study Using Nurses and Volunteers
CPR Training using the Family and Friends CPR Anytime VSI Kit, Implementation of an In-Hospital CPR Training Model - Cardiovascular Risk Factors, Coronary Disease
Phase 1 / Phase 2CompletedUniversity of Pennsylvania5002010-10-012018-11-01
Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO)
Fluconazole - Cardiopulmonary Arrest, Fungal Infection
Phase 1CompletedMichael Cohen-Wolkowiez212010-07-012017-11-22
Pilot Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients
nitrite - Cardiac Arrest
Phase 1CompletedUniversity of Washington112010-01-012017-05-18

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Death, Sudden, Cardiac (7)  ·  Hypothermia (4)  ·  Ventricular Fibrillation (3)  ·  Arrhythmogenic Right Ventricular Dysplasia (2)  ·  Coma (2)  ·  Coronary Disease (2)  ·  Out-of-Hospital Cardiac Arrest (2)  ·  Reperfusion Injury (2)  ·  Tachycardia, Ventricular (2)  ·  Blood Coagulation Disorders (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Death (1)  ·  Death, Sudden (1)

Broader conditions

Cardiovascular Diseases (28)  ·  Heart Diseases (28)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Pathologic Processes (11)  ·  Signs and Symptoms (7)  ·  Death (6)  ·  Death, Sudden (6)  ·  Vascular Diseases (5)  ·  Arrhythmias, Cardiac (4)  ·  Body Temperature Changes (4)  ·  Nervous System Diseases (4)  ·  Neurologic Manifestations (3)  ·  Cardiac Conduction System Disease (2)  ·  Cardiovascular Abnormalities (2)

Interventions

Sodium Chloride (5)  ·  Drug Delivery Systems (2)  ·  Standard of Care (2)  ·  2-iminobiotin (1)  ·  Circulatory Arrest, Deep Hypothermia Induced (1)  ·  Clinical Protocols (1)  ·  Epinephrine (1)  ·  Fluconazole (1)  ·  Health Services Needs and Demand (1)  ·  Hydrocortisone (1)  ·  Hydrogen (1)  ·  Hypothermia, Induced (1)  ·  Ketamine (1)  ·  Magnesium Sulfate (1)  ·  Morphine (1)

Sponsors

University of Washington (4)  ·  Life Recovery Systems (2)  ·  NYU Langone Health (2)  ·  University of Pennsylvania (2)  ·  Aalborg University Hospital (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Bayside Health (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Boston Children's Hospital (1)  ·  Foundation for Atlanta Veterans Education and Research, Inc. (1)  ·  Gilead Sciences (1)  ·  Hibernaid, Inc (1)  ·  Lexeo Therapeutics (1)  ·  Medical University of Vienna (1)  ·  Michael Cohen-Wolkowiez (1)

Countries

United States (19)  ·  Austria (2)  ·  Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Francis Kim, MD (3)  ·  Benjamin S Abella, MD, MPhil (2)  ·  A. Maziar Zafari, M.D., Ph.D (1)  ·  Barry Greenberg, MD (1)  ·  Cynthia Dougherty, ARNP, PhD (1)  ·  Daniel Howes, M.D. (1)  ·  David B Seder, MD (1)  ·  Dorian Paul, MD (1)  ·  Graham Nichol, MD (1)  ·  Janneke Horn, MD, PhD (1)  ·  Johannes Scherr, Dr. med. (1)  ·  John N Kheir, MD (1)  ·  Kevin M Watt, MD (1)

Results publications

PMID 18547438, PMID 22080629, PMID 24559067, PMID 26093876, PMID 27038920, PMID 29370708, PMID 30205886, PMID 37979797, PMID 39428602, PMID 41204320

NIH funding

R01HL112815 (1), R01NR004766 (1), R34HL166859 (1)